Switch to:

Reminder: Cancer Drug Preauthorization List Expands in August

Switch to:
Switch to:

Search

Popular Tasks

Contact Us

Neighborhood Care

Reminder: Cancer Drug Preauthorization List Expands in August

07/28/2021

Starting Aug. 15, 2021, more oncology-related chemotherapeutic drugs and supportive agents will require preauthorization when delivered in the physician’s office, outpatient hospital, or other ambulatory setting. See EmblemHealth’s Frequently Asked Questions: EmblemHealth Oncology Drug Management and ConnectiCare’s Pharmacy Policies to determine where to submit the preauthorization request. 

Provider Update

ALSO OF INTEREST

Oncology Drug Program - Additional Codes Require Preauthorization Effective August 15, 2021 Pluvicto™ Added To Preauthorization List August 1, 2022 Preauthorization List Updates
provider

Language Assistance:

© 2023 EmblemHealth. All Rights Reserved.

Any information provided on this Website is for informational purposes only. It is not medical advice and should not be substituted for regular consultation with your health care provider. If you have any concerns about your health, please contact your health care provider's office.

Also, this information is not intended to imply that services or treatments described in the information are covered benefits under your plan. Please refer to your Membership Agreement, Certificate of Coverage, Benefit Summary, or other plan documents for specific information about your benefits coverage.